|1.||Sanefuji, Hayato: 1 article (01/2015)|
|2.||Liu, Ning: 1 article (01/2015)|
|3.||Shi, Junfeng: 1 article (01/2015)|
|4.||Tsujimoto, Gozoh: 1 article (01/2015)|
|5.||Takei, Yoshinori: 1 article (01/2015)|
|6.||Yasue, Misato: 1 article (01/2015)|
|7.||Hirasawa, Akira: 1 article (01/2015)|
|8.||Xiao, Ying: 1 article (01/2015)|
|9.||Borges, Karin: 1 article (01/2014)|
|10.||McDonald, Tanya S: 1 article (01/2014)|
01/01/2001 - "Trioctanoin injected intraperitoneally in pregnant rats was associated with an increase in mammary tumors in the offspring compared to that seen in offspring of untreated animals, but similar studies in pregnant hamsters and rabbits showed no tumors in the offspring. "
01/01/2001 - "Trioctanoin injected subcutaneously in hamsters produced no tumors. "
10/01/1995 - "A single ip dose of B[alpha]P (1.79 mg in 0.25 mL of tricaprylin) resulted in 100% lung tumorigenesis with a multiplicity of 15.79 tumors/mouse. "
11/01/1986 - "Therefore, BTC produced a significant (P less than 0.001) and dose-related increase in the lung tumor response when compared to tricaprylin controls and is a potent carcinogen in the strain A mouse lung tumor bioassay."
11/01/1986 - "Tricaprylin-vehicle controls had a mean number of 0.46 +/- 0.15 lung tumors per mouse. "
|3.||Exocrine Pancreatic Insufficiency
06/01/1990 - "The [13C]trioctanoin breath test may prove a safe, non-invasive technique not only for the detection of pancreatic insufficiency, but also for the quantitative study of intraluminal lipolysis."
06/01/1990 - "Six subjects with cystic fibrosis and pancreatic insufficiency and 10 controls received a test meal containing [13C] trioctanoin, and breath 13CO2 was measured using a dual inlet, dual detector isotope ratio mass spectrometer. "
05/01/1982 - "In 6 out of 6 cases, pancreatic insufficiency could be differentiated from mucosal disease (7 patients) or bile salt deficiency (4 patients) by the presence of abnormal triolein or trioctanoin breath tests, or both but normal palmitic acid breath tests. "
04/01/1998 - "With the aim to determine whether steatorrhea is due to pancreatic insufficiency, several 14C- (or 13C) breath tests have been developed in which triolein, trioctanoin, tripalmitin, and cholesteryl-octanoate are used as marker substances. "
|5.||Body Weight (Weight, Body)
06/01/2004 - "After PH they were administered either trioctanoin alone (groups A', B', C' and D') or a single injection of DEN in trioctanoin at a dose of 10 mg/kg of body weight (groups A, B, C and D). "
07/01/1998 - "injection of benzo[a]pyrene (B[a]P) (200 mg/kg body weight dissolved in tricaprylin). "
02/01/1986 - "injection of N-nitrosodiethylamine (DEN, 90 mg/kg body weight) or the solvent tricaprylin (10 ml/kg). "
02/01/2002 - "Following treatment of rats with 4-OHE2 (6 micromol/100 g body weight in 200 microl of trioctanoin/dimethylsulfoxide (4:1) by intraperitoneal injection) for 90 min, the non-susceptible ventral (VP) and anterior (AP) prostate had higher levels of 4-methoxyCE and GSH conjugates than the susceptible dorsolateral prostate (DLP) and periurethral prostate (PUP). "
09/01/1989 - "injection of N-nitrosodiethylamine (NDEA; 90 mg/kg body weight) in tricaprylin, followed by administration of either phenobarbital (PB; 0.05%) or CZP (0.068% or 0.136%) in diet beginning 2 weeks after carcinogen injection and continuing to 60 weeks of age. "
|3.||caprylic acid (octanoate)
|6.||3-Hydroxybutyric Acid (beta-Hydroxybutyric Acid)
|8.||Palmitic Acid (Hexadecanoic Acid)
|10.||Serpentine Asbestos (Chrysotile)